The relation between inflammatory markers and pulmonary infiltration in chlamydia pneumonia

Abstract

AimWe aimed to describe the levels of leucocyte count, erythrocyte sedimen-tation rate (ESR) and high sensitive C-Reactive Protein (hsCRP), and to in-vestigate the relation of these biomarkers with the ratio of parenchymal infiltration (RPI) in patients with Chlamydia pneumoniae pneumonia (CPP).MethodsThe diagnosis of CPP was based on serologic testing. Patients with CPP were analyzed the blood leucocyte counts, ESR and hsCRP levels. The parenchymal infiltration ratio, given as percent, was calculated from the high resolution computerized tomography (HRCT) images using the following formula: Pulmonary infiltration ratio = number of images showing infiltration in HRCT x 100 / number of all images x 2. The relation of the extent of the infiltrated lung parenchyma, shown by HRCT, with the leucocyte count, ESR and sCRP was investigated.ResultsThirty two patients with CPP were included this study. Increasing levels of blood leucocyte counts in 14 (43.7 %), ESR in 27 (84.3 %) and hsCRP in 26 (81.2%) patients were observed. High sensitive CRP was moderately but significantly correlated with RPI (r = 0.476, P = 0.006). However, RPI was not significantly correlated with blood leucocyte count and ESR (r = 0,011, P = 0,952 ve r = 0,102, P = 0,580, respectively).ConclusionsAlthough both ESR and hsCRP were useful to detect infection, only hsCRP was correlated with the extent of parenchymal infiltration. Therefore, as a parameter sCRP can be used to evaluate the severity of CPP but larger series are needed to confirm this finding.

Keywords

Additional Information

Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.

Rights and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/

View full license details →